Table 2.
Number of Eyes Ever Developing POAG During the Study
| No. of Eyes per Patient Ever Developing Conditiona | No. (%)
|
||
|---|---|---|---|
| Medication Group | Observation Group | All | |
| POAG | |||
| 0 | 702 (85.9) | 655 (80.0) | 1357 (82.9) |
| 1 | 83 (10.2) | 113 (13.8) | 196 (12.0) |
| 2 | 32 (3.9) | 51 (6.2) | 83 (5.1) |
| Visual field POAG | |||
| 0 | 744 (91.1) | 717 (87.5) | 1461 (89.3) |
| 1 | 63 (7.7) | 83 (10.1) | 146 (8.9) |
| 2 | 10 (1.2) | 19 (2.3) | 29 (1.8) |
| Optic disc POAG | |||
| 0 | 728 (89.1) | 688 (84.0) | 1416 (86.6) |
| 1 | 64 (7.8) | 89 (10.9) | 153 (9.4) |
| 2 | 25 (3.1) | 42 (5.1) | 67 (4.0) |
| Visual field and optic disc POAG | |||
| 0 | 774 (94.7) | 752 (91.8) | 1526 (93.3) |
| 1 | 36 (4.4) | 55 (6.7) | 91 (5.5) |
| 2 | 7 (0.9) | 12 (1.5) | 19 (1.2) |
Abbreviation: POAG, primary open-angle glaucoma.
a
The groups are not mutually exclusive.